Evidence map›Paper›PMID 40144516›Full record

ArticleFrontiers in pain research (Lausanne, Switzerland)2025

Exploring the value of a well-established conditioned pain modulation paradigm in women: a Translational Research in Pelvic Pain (TRiPP) study.

Lysia Demetriou, Danielle Perro, Lydia Coxon, Michal Krassowski, Claire E Lunde, Joana Ferreira-Gomes, Ana Charrua, Pedro Abreu-Mendes, Lars Arendt-Nielsen, Qasim Aziz and 21 more

Abstract read
In one paragraph

Article in Frontiers in pain research (Lausanne, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Lysia Demetriou *Nuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Danielle Perro *Nuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Lydia Coxon *Nuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Michal KrassowskiNuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Claire E LundeNuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Joana Ferreira-GomesIBMC/I3S and Faculty of Medicine of Porto Hospital S João, Porto, Portugal.
Ana CharruaIBMC/I3S and Faculty of Medicine of Porto Hospital S João, Porto, Portugal.
Pedro Abreu-MendesIBMC/I3S and Faculty of Medicine of Porto Hospital S João, Porto, Portugal.
Lars Arendt-NielsenDepartment of Health Science and Technology, Center for Neuroplasticity and Pain (CNAP), SMI, School of Medicine, Aalborg University, Aalborg, Denmark.
Qasim AzizCentre for Neuroscience, Surgery and Trauma, Blizard Institute, Wingate Institute of Neurogastroenterology, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Judy BirchPelvic Pain Support Network, Poole, United Kingdom.
Kurtis GarbuttNuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Andrew HorneMRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, United Kingdom.
Anja HoffmanResearch & Development, Pharmaceuticals Experimental Medicine, Bayer AG, Berlin, Germany.
Lone HummelshojEndometriosis.org, London, United Kingdom.
Jane MeijlinkInternational Painful Bladder Foundation, Amsterdam, Netherlands.
Maik ObendorfResearch & Development, Pharmaceuticals Experimental Medicine, Bayer AG, Berlin, Germany.
Esther Pogatzki-ZahnDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, Muenster, Germany.
Naoko SasamotoDepartment of Obstetrics and Gynaecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Kathryn TerryDepartment of Obstetrics and Gynaecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Rolf-Detlef TreedeDepartment of Neurophysiology, Mannheim Center for Translational Neuroscience (MCTN), Heidelberg University, Mannheim, Germany.
Allison VitonisDepartment of Obstetrics and Gynaecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Jan VollertDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.
Nilufer RahmiogluNuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Christian M BeckerNuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Francisco CruzIBMC/I3S and Faculty of Medicine of Porto Hospital S João, Porto, Portugal.
Stacey A MissmerBoston Center for Endometriosis, Brigham and Women's Hospital and Boston Children's Hospital, Boston, MA, United States.
Krina ZondervanNuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.
Christine B SiebergDivision of Adolescent & Young Adult Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
Jens NagelExploratory Pathobiology, Research & Development, Pharmaceuticals, Bayer Aktiengesellschaft, Wuppertal, Germany.
Katy VincentNuffield Department of Women's and Reproductive Health, Oxford Endometriosis Centre, University of Oxford, Oxforfd, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Conditioned pain modulation (CPM) is considered a human proxy for descending inhibitory pain pathways. However, there is wide variation in the CPM response described in the literature and ongoing debate about its utility. Methods: Here we explored CPM in women with ( Results: Using a pressure pain threshold test stimulus and ischaemic pressure cuff conditioning stimulus (CS), we found no significant difference in the mean CPM effect between CPP and control participants. Using a robust statistical method (+/-2 standard error of measurement) to further investigate CPM, there was no significant difference in the proportion exhibiting inhibition between controls and CPP participants ( Conclusions: Despite using one of the recommended CPM paradigms we were only able to demonstrate "true" CPM in 23.1% of control participants. Thus, the absence of differences between women with and without chronic pelvic pain must be interpreted with caution. Future studies using different CPM paradigms or larger sample sizes may find different results. Although CPM in chronic pain populations is of major theoretical mechanistic interest, the lack of an established assessment standard led us to question its added value in current clinical research.

Indexed as

chronic pelvic painconditioned pain modulationpain characteristicsquantitative sensory testingwomen's health

Identifiers

PMID40144516
PMCPMC11936887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.